 | • レポートコード：D0804-05300 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、注射用コバマミドの世界市場を広く調査・分析し、今後の市場展望をまとめております。注射用コバマミドの種類別市場規模（0.5mg、1.0mg、1.5mg）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Haerbin Medisan、Hainan Star Pharmaceutical、North China Pharmaceutical Group、Jiuquan Dadeli pharmaceutical、Chongqing Yaoyou Pharmaceutical、Jiangsu Jiuxu Pharmaceutical、Hebei Zhitong Biopharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・注射用コバマミドの北米市場（アメリカ、カナダ、メキシコ） ・注射用コバマミドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・注射用コバマミドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・注射用コバマミドの南米市場（ブラジル、アルゼンチン） ・注射用コバマミドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：0.5mg、1.0mg、1.5mg ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Cobamamide for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cobamamide for Injection sales will be xx in 2020 from Cobamamide for Injection million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cobamamide for Injection market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cobamamide for Injection industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cobamamide for Injection and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cobamamide for Injection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cobamamide for Injection market has been segmented into
0.5mg
1.0mg
1.5mg
By Application, Cobamamide for Injection has been segmented into:
Hospital
Drug Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cobamamide for Injection market presented in the report. This section sheds light on the sales growth of different regional and country-level Cobamamide for Injection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cobamamide for Injection market.
The report offers in-depth assessment of the growth and other aspects of the Cobamamide for Injection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cobamamide for Injection Market Share Analysis
Cobamamide for Injection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cobamamide for Injection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cobamamide for Injection sales, revenue and market share for each player covered in this report.
The major players covered in Cobamamide for Injection are:
Haerbin Medisan
Hainan Star Pharmaceutical
North China Pharmaceutical Group
Jiuquan Dadeli pharmaceutical
Chongqing Yaoyou Pharmaceutical
Jiangsu Jiuxu Pharmaceutical
Hebei Zhitong Biopharmaceutical
Among other players domestic and global, Cobamamide for Injection market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cobamamide for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cobamamide for Injection, with price, sales, revenue and global market share of Cobamamide for Injection in 2018 and 2019.
Chapter 3, the Cobamamide for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cobamamide for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cobamamide for Injection market forecast, by regions, injection and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cobamamide for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cobamamide for Injection Introduction
1.2 Market Analysis by Injection
1.2.1 Overview: Global Cobamamide for Injection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Cobamamide for Injection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Overview of Global Cobamamide for Injection Market
1.4.1 Global Cobamamide for Injection Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Cobamamide for Injection Industry Impact
1.6.1 COVID-19 Potential Implications for the Cobamamide for Injection
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cobamamide for Injection
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Haerbin Medisan
2.1.1 Haerbin Medisan Details
2.1.2 Haerbin Medisan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Haerbin Medisan SWOT Analysis
2.1.4 Haerbin Medisan Product and Services
2.1.5 Haerbin Medisan Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hainan Star Pharmaceutical
2.2.1 Hainan Star Pharmaceutical Details
2.2.2 Hainan Star Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hainan Star Pharmaceutical SWOT Analysis
2.2.4 Hainan Star Pharmaceutical Product and Services
2.2.5 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 North China Pharmaceutical Group
2.3.1 North China Pharmaceutical Group Details
2.3.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 North China Pharmaceutical Group SWOT Analysis
2.3.4 North China Pharmaceutical Group Product and Services
2.3.5 North China Pharmaceutical Group Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Jiuquan Dadeli pharmaceutical
2.4.1 Jiuquan Dadeli pharmaceutical Details
2.4.2 Jiuquan Dadeli pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Jiuquan Dadeli pharmaceutical SWOT Analysis
2.4.4 Jiuquan Dadeli pharmaceutical Product and Services
2.4.5 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chongqing Yaoyou Pharmaceutical
2.5.1 Chongqing Yaoyou Pharmaceutical Details
2.5.2 Chongqing Yaoyou Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Chongqing Yaoyou Pharmaceutical SWOT Analysis
2.5.4 Chongqing Yaoyou Pharmaceutical Product and Services
2.5.5 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Jiangsu Jiuxu Pharmaceutical
2.6.1 Jiangsu Jiuxu Pharmaceutical Details
2.6.2 Jiangsu Jiuxu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Jiangsu Jiuxu Pharmaceutical SWOT Analysis
2.6.4 Jiangsu Jiuxu Pharmaceutical Product and Services
2.6.5 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hebei Zhitong Biopharmaceutical
2.7.1 Hebei Zhitong Biopharmaceutical Details
2.7.2 Hebei Zhitong Biopharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hebei Zhitong Biopharmaceutical SWOT Analysis
2.7.4 Hebei Zhitong Biopharmaceutical Product and Services
2.7.5 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cobamamide for Injection Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cobamamide for Injection Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cobamamide for Injection Manufacturer Market Share in 2019
3.3.2 Top 6 Cobamamide for Injection Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cobamamide for Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Cobamamide for Injection Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cobamamide for Injection Revenue and Market Share by Regions (2015-2020)
4.2 North America Cobamamide for Injection Sales and Growth Rate (2015-2020)
4.3 Europe Cobamamide for Injection Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cobamamide for Injection Sales and Growth Rate (2015-2020)
4.5 South America Cobamamide for Injection Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cobamamide for Injection Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cobamamide for Injection Sales, Revenue and Market Share by Country
5.1.1 North America Cobamamide for Injection Sales and Market Share by Country (2015-2020)
5.1.2 North America Cobamamide for Injection Revenue and Market Share by Country (2015-2020)
5.2 United States Cobamamide for Injection Sales and Growth Rate (2015-2020)
5.3 Canada Cobamamide for Injection Sales and Growth Rate (2015-2020)
5.4 Mexico Cobamamide for Injection Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cobamamide for Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Cobamamide for Injection Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cobamamide for Injection Revenue and Market Share by Country (2015-2020)
6.2 Germany Cobamamide for Injection Sales and Growth Rate (2015-2020)
6.3 UK Cobamamide for Injection Sales and Growth Rate (2015-2020)
6.4 France Cobamamide for Injection Sales and Growth Rate (2015-2020)
6.5 Russia Cobamamide for Injection Sales and Growth Rate (2015-2020)
6.6 Italy Cobamamide for Injection Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cobamamide for Injection Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cobamamide for Injection Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cobamamide for Injection Revenue and Market Share by Regions (2015-2020)
7.2 China Cobamamide for Injection Sales and Growth Rate (2015-2020)
7.3 Japan Cobamamide for Injection Sales and Growth Rate (2015-2020)
7.4 Korea Cobamamide for Injection Sales and Growth Rate (2015-2020)
7.5 India Cobamamide for Injection Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cobamamide for Injection Sales and Growth Rate (2015-2020)
7.7 Australia Cobamamide for Injection Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cobamamide for Injection Sales, Revenue and Market Share by Country
8.1.1 South America Cobamamide for Injection Sales and Market Share by Country (2015-2020)
8.1.2 South America Cobamamide for Injection Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cobamamide for Injection Sales and Growth Rate (2015-2020)
8.3 Argentina Cobamamide for Injection Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cobamamide for Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cobamamide for Injection Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cobamamide for Injection Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cobamamide for Injection Sales and Growth Rate (2015-2020)
9.3 Turkey Cobamamide for Injection Sales and Growth Rate (2015-2020)
9.4 Egypt Cobamamide for Injection Sales and Growth Rate (2015-2020)
9.5 South Africa Cobamamide for Injection Sales and Growth Rate (2015-2020)
10 Market Segment by Injection
10.1 Global Cobamamide for Injection Sales and Market Share by Injection (2015-2020)
10.2 Global Cobamamide for Injection Revenue and Market Share by Injection (2015-2020)
10.3 Global Cobamamide for Injection Price by Injection (2015-2020)
11 Global Cobamamide for Injection Market Segment by Application
11.1 Global Cobamamide for Injection Sales Market Share by Application (2015-2020)
11.2 Global Cobamamide for Injection Revenue Market Share by Application (2015-2020)
11.3 Global Cobamamide for Injection Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cobamamide for Injection Sales, Revenue and Growth Rate (2021-2025)
12.2 Cobamamide for Injection Market Forecast by Regions (2021-2025)
12.2.1 North America Cobamamide for Injection Market Forecast (2021-2025)
12.2.2 Europe Cobamamide for Injection Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cobamamide for Injection Market Forecast (2021-2025)
12.2.4 South America Cobamamide for Injection Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cobamamide for Injection Market Forecast (2021-2025)
12.3 Cobamamide for Injection Market Forecast by Injection (2021-2025)
12.3.1 Global Cobamamide for Injection Sales Forecast by Injection (2021-2025)
12.3.2 Global Cobamamide for Injection Market Share Forecast by Injection (2021-2025)
12.4 Cobamamide for Injection Market Forecast by Application (2021-2025)
12.4.1 Global Cobamamide for Injection Sales Forecast by Application (2021-2025)
12.4.2 Global Cobamamide for Injection Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cobamamide for Injection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cobamamide for Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cobamamide for Injection Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Cobamamide for Injection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Haerbin Medisan Basic Information, Manufacturing Base and Competitors
Table 9. Haerbin Medisan Cobamamide for Injection Major Business
Table 10. Haerbin Medisan Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 11. Haerbin Medisan SWOT Analysis
Table 12. Haerbin Medisan Cobamamide for Injection Product and Services
Table 13. Haerbin Medisan Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Hainan Star Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 15. Hainan Star Pharmaceutical Cobamamide for Injection Major Business
Table 16. Hainan Star Pharmaceutical Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 17. Hainan Star Pharmaceutical SWOT Analysis
Table 18. Hainan Star Pharmaceutical Cobamamide for Injection Product and Services
Table 19. Hainan Star Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. North China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 21. North China Pharmaceutical Group Cobamamide for Injection Major Business
Table 22. North China Pharmaceutical Group Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 23. North China Pharmaceutical Group SWOT Analysis
Table 24. North China Pharmaceutical Group Cobamamide for Injection Product and Services
Table 25. North China Pharmaceutical Group Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Jiuquan Dadeli pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 27. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Major Business
Table 28. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 29. Jiuquan Dadeli pharmaceutical SWOT Analysis
Table 30. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product and Services
Table 31. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Chongqing Yaoyou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 33. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Major Business
Table 34. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 35. Chongqing Yaoyou Pharmaceutical SWOT Analysis
Table 36. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product and Services
Table 37. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Jiangsu Jiuxu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Major Business
Table 40. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 41. Jiangsu Jiuxu Pharmaceutical SWOT Analysis
Table 42. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product and Services
Table 43. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Hebei Zhitong Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 45. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Major Business
Table 46. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Total Revenue (USD Million) (2018-2019)
Table 47. Hebei Zhitong Biopharmaceutical SWOT Analysis
Table 48. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product and Services
Table 49. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Cobamamide for Injection Sales by Manufacturer (2018-2019) (Kg)
Table 51. Global Cobamamide for Injection Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Cobamamide for Injection Sales by Regions (2015-2020) (Kg)
Table 53. Global Cobamamide for Injection Sales Market Share by Regions (2015-2020)
Table 54. Global Cobamamide for Injection Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Cobamamide for Injection Sales by Countries (2015-2020) (Kg)
Table 56. North America Cobamamide for Injection Sales Market Share by Countries (2015-2020)
Table 57. North America Cobamamide for Injection Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Cobamamide for Injection Revenue Market Share by Countries (2015-2020)
Table 59. Europe Cobamamide for Injection Sales by Countries (2015-2020) (Kg)
Table 60. Europe Cobamamide for Injection Sales Market Share by Countries (2015-2020)
Table 61. Europe Cobamamide for Injection Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Cobamamide for Injection Sales by Regions (2015-2020) (Kg)
Table 63. Asia-Pacific Cobamamide for Injection Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Cobamamide for Injection Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Cobamamide for Injection Sales by Countries (2015-2020) (Kg)
Table 66. South America Cobamamide for Injection Sales Market Share by Countries (2015-2020)
Table 67. South America Cobamamide for Injection Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Cobamamide for Injection Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Cobamamide for Injection Sales by Countries (2015-2020) (Kg)
Table 70. Middle East & Africa Cobamamide for Injection Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Cobamamide for Injection Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Cobamamide for Injection Revenue Market Share by Countries (2015-2020)
Table 73. Global Cobamamide for Injection Sales by Type (2015-2020) (Kg)
Table 74. Global Cobamamide for Injection Sales Share by Type (2015-2020)
Table 75. Global Cobamamide for Injection Revenue by Type (2015-2020) (USD Million)
Table 76. Global Cobamamide for Injection Revenue Share by Type (2015-2020)
Table 77. Global Cobamamide for Injection Sales by Application (2015-2020) (Kg)
Table 78. Global Cobamamide for Injection Sales Share by Application (2015-2020)
Table 79. Global Cobamamide for Injection Sales Forecast by Regions (2021-2025) (Kg)
Table 80. Global Cobamamide for Injection Market Share Forecast by Regions (2021-2025)
Table 81. Global Cobamamide for Injection Sales Forecast by Type (2021-2025) (Kg)
Table 82. Global Cobamamide for Injection Market Share Forecast by Type (2021-2025)
Table 83. Global Cobamamide for Injection Sales Forecast by Application (2021-2025)
Table 84. Global Cobamamide for Injection Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cobamamide for Injection Picture
Figure 2. Global Sales Market Share of Cobamamide for Injection by Injection in 2019
Figure 3. 0.5mg Picture
Figure 4. 1.0mg Picture
Figure 5. 1.5mg Picture
Figure 6. Cobamamide for Injection Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drug Store Picture
Figure 9. Other Picture
Figure 10. Global Cobamamide for Injection Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Cobamamide for Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Cobamamide for Injection Sales Market Share by Manufacturer in 2019
Figure 31. Global Cobamamide for Injection Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Cobamamide for Injection Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Cobamamide for Injection Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 36. Global Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Cobamamide for Injection Revenue Market Share by Regions (2015-2020)
Figure 38. Global Cobamamide for Injection Revenue Market Share by Regions in 2018
Figure 39. North America Cobamamide for Injection Sales and Growth Rate (2015-2020)
Figure 40. Europe Cobamamide for Injection Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cobamamide for Injection Sales and Growth Rate (2015-2020)
Figure 42. South America Cobamamide for Injection Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Cobamamide for Injection Sales and Growth Rate (2015-2020)
Figure 44. North America Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Cobamamide for Injection Sales Market Share by Countries (2015-2020)
Figure 46. North America Cobamamide for Injection Sales Market Share by Countries in 2018
Figure 47. North America Cobamamide for Injection Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Cobamamide for Injection Revenue Market Share by Countries in 2018
Figure 49. United States Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 50. Canada Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 51. Mexico Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 52. Europe Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Cobamamide for Injection Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Cobamamide for Injection Revenue Market Share by Countries in 2019
Figure 55. Germany Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 56. UK Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 57. France Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 58. Russia Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 59. Italy Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 60. Asia-Pacific Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Cobamamide for Injection Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Cobamamide for Injection Revenue Market Share by Regions 2019
Figure 63. China Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 64. Japan Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 65. Korea Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 66. India Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 67. Southeast Asia Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 68. South America Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Cobamamide for Injection Sales Market Share by Countries in 2019
Figure 70. South America Cobamamide for Injection Revenue Market Share by Countries in 2019
Figure 71. Brazil Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 72. Argentina Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 73. Middle East and Africa Cobamamide for Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Cobamamide for Injection Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Cobamamide for Injection Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Cobamamide for Injection Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 78. Egypt Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 79. Turkey Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 80. South Africa Cobamamide for Injection Sales and Growth Rate (2015-2020) (Kg)
Figure 81. Global Cobamamide for Injection Sales and Growth Rate (2021-2025) (Kg)
Figure 82. Global Cobamamide for Injection Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Cobamamide for Injection Market Forecast (2021-2025) (Kg)
Figure 84. Europe Sales Cobamamide for Injection Market Forecast (2021-2025) (Kg)
Figure 85. Asia-Pacific Sales Cobamamide for Injection Market Forecast (2021-2025) (Kg)
Figure 86. South America Sales Cobamamide for Injection Market Forecast (2021-2025) (Kg)
Figure 87. Middle East & Africa Sales Cobamamide for Injection Market Forecast (2021-2025) (Kg)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
注射用コバマミドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Cobamamide for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- コバマミド薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Cobamamide Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 牛脳グリコシド・イグノチン注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cattle Encephalon Glycoside and Ignotin Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…
- 注射用ミカファンギンナトリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 注射用マウス神経成長因子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mouse Nerve Growth Factor for Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mouse…